(MENAFN- GlobeNewsWire - Nasdaq) The main market opportunities in tissue factor-targeted immunotherapies include developing advanced ADCs for cancers with high TF expression like NSCLC, pancreatic, ...
Dublin, Nov. 27, 2025 (GLOBE NEWSWIRE) -- The "Pipeline of Tissue Factor-Targeted Immunotherapies" report has been added to ResearchAndMarkets.com's offering. This competitive intelligence report ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback